Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IONSIONIS PHARMACEUTICALS INC

Nasdaq · CIK 0000874015
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts454

Identity from submissions API

NameIONIS PHARMACEUTICALS INC
CIK0000874015
TickersIONS
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN330336973
LEI—
Fiscal year end1231
State of incorporationCA CA
Phone7609319200
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • ISIS PHARMACEUTICALS INC (1996-06-12T00:00:00.000Z → 2015-12-18T00:00:00.000Z)
Business address
2855 GAZELLE COURT
CARLSBAD
CA
92010
CA
Mailing address
2855 GAZELLE COURT
CARLSBAD
CA
92010
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

2696 filing rows loaded from submissions recent; extra archives: CIK0000874015-submissions-001.json (1688 filings, 1996-06-12 to 2020-07-04).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 4 PRIMARY DOCUMENT 0000874015-26-000273 6316
2026-11-09 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) 0000874015-26-000271 000-19125 261533999 34 8251476 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001140361-26-042598 000-19125 261533751 34 409246 1 1
2026-10-23 8-K 8-K 7.01,8.01,9.01 0001140361-26-040631 000-19125 261481640 34 186319 1 1
2026-10-21 8-K 8-K 7.01,8.01,9.01 0001140361-26-040388 000-19125 261475853 34 210357 1 1
2026-10-19 4 PRIMARY DOCUMENT 0000874015-26-000267 9633
2026-10-19 4 PRIMARY DOCUMENT 0000874015-26-000266 9910
2026-10-16 144 xsl144X01/primary_doc.xml 0000874015-26-000263 000-19125 261466974 33 4272
2026-09-23 8-K CURRENT REPORT FILING 7.01,8.01,9.01 0001140361-26-037371 000-19125 261398137 34 187752 1 1
2026-09-04 8-K 8-K 7.01,8.01,9.01 0001140361-26-035802 000-19125 261362732 34 181066 1 1
2026-09-04 8-K 8-K 7.01,8.01,9.01 0001140361-26-035657 000-19125 261360083 34 206926 1 1
2026-09-02 4 PRIMARY DOCUMENT 0000874015-26-000262 5002
2026-09-02 4 PRIMARY DOCUMENT 0000874015-26-000261 4904
2026-09-02 4 PRIMARY DOCUMENT 0000874015-26-000260 4933
2026-09-02 4 PRIMARY DOCUMENT 0000874015-26-000259 4941
2026-07-31 4 PRIMARY DOCUMENT 0000874015-26-000254 8263
2026-07-31 S-8 S-8 0001140361-26-030454 333-297873 261227705 33 228762 1 1
2026-07-29 10-Q IONIS PHARMACEUTICALS, INC. 10-Q 06-30-2026 0000874015-26-000251 000-19125 261218803 34 7913959 1 1
2026-07-29 8-K 8-K 2.02,9.01 0001140361-26-029960 000-19125 261213974 34 638149 1 1
2026-07-17 4 PRIMARY DOCUMENT 0000874015-26-000247 6001
2026-07-17 4 PRIMARY DOCUMENT 0000874015-26-000246 5956
2026-07-17 4 PRIMARY DOCUMENT 0000874015-26-000245 7511
2026-07-17 4 PRIMARY DOCUMENT 0000874015-26-000244 8573
2026-07-10 8-K 8-K 7.01,9.01 0001140361-26-028154 000-19125 261166795 34 155003 1 1
2026-07-09 4 PRIMARY DOCUMENT 0000874015-26-000239 11597
2026-07-09 4 PRIMARY DOCUMENT 0000874015-26-000237 8792
2026-07-09 4 PRIMARY DOCUMENT 0000874015-26-000236 4950
2026-07-09 8-K 8-K 7.01,8.01,9.01 0001140361-26-028092 000-19125 261165416 34 191710 1 1
2026-07-07 144 xsl144X01/primary_doc.xml 0001972481-26-000227 000-19125 261159689 33 4426
2026-07-07 144 xsl144X01/primary_doc.xml 0001972481-26-000226 000-19125 261159622 33 5129
2026-07-07 144 xsl144X01/primary_doc.xml 0001972481-26-000225 000-19125 261159608 33 5155
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000232 9247
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000231 9019
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000230 9014
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000229 17222
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000228 9255
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000227 9274
2026-07-06 4 PRIMARY DOCUMENT 0000874015-26-000226 9047
2026-07-01 144 xsl144X01/primary_doc.xml 0001972481-26-000222 000-19125 261146669 33 4439
2026-06-30 4 PRIMARY DOCUMENT 0000874015-26-000218 13416
2026-06-30 4 PRIMARY DOCUMENT 0000874015-26-000217 4814
2026-06-30 4 PRIMARY DOCUMENT 0000874015-26-000216 8863
2026-06-26 4 PRIMARY DOCUMENT 0000874015-26-000212 19585
2026-06-26 4 PRIMARY DOCUMENT 0000874015-26-000211 6066
2026-06-26 144 xsl144X01/primary_doc.xml 0001972481-26-000215 000-19125 261130803 33 4960
2026-06-26 144 xsl144X01/primary_doc.xml 0001972481-26-000214 000-19125 261130798 33 4442
2026-06-26 144 xsl144X01/primary_doc.xml 0001972481-26-000213 000-19125 261130781 33 5004
2026-06-25 144 xsl144X01/primary_doc.xml 0001972481-26-000211 000-19125 261123466 33 6587
2026-06-24 8-K 8-K 7.01,8.01,9.01 0001140361-26-026232 000-19125 261115711 34 254146 1 1
2026-06-16 4 PRIMARY DOCUMENT 0000874015-26-000208 21100
2026-06-16 4 PRIMARY DOCUMENT 0000874015-26-000207 9275
2026-06-15 144 xsl144X01/primary_doc.xml 0001959173-26-004629 000-19125 261089357 33 5059
2026-06-12 144 xsl144X01/primary_doc.xml 0001972481-26-000192 000-19125 261087207 33 5622
2026-06-12 8-K 8-K 8.01,9.01 0001140361-26-025050 000-19125 261086034 34 155246 1 1
2026-06-08 4 PRIMARY DOCUMENT 0000874015-26-000203 5787
2026-06-08 4 PRIMARY DOCUMENT 0000874015-26-000202 5742
2026-06-08 3 PRIMARY DOCUMENT 0000874015-26-000201 3109
2026-06-08 3 PRIMARY DOCUMENT 0000874015-26-000200 3064
2026-06-08 8-K 8-K 5.02,5.07,7.01,9.01 0001140361-26-024407 000-19125 261071849 34 200319 1 1
2026-06-03 4 PRIMARY DOCUMENT 0000874015-26-000188 9233
2026-06-01 144 xsl144X01/primary_doc.xml 0001959173-26-004164 000-19125 261048015 33 4483
2026-05-28 8-K 8-K 7.01,8.01,9.01 0001140361-26-023093 000-19125 261031848 34 208847 1 1
2026-05-15 4 PRIMARY DOCUMENT 0000874015-26-000185 14217
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000462 005-41771 26983378 34 7752
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000098 005-41771 26977707 34 7492
2026-05-13 144 xsl144X01/primary_doc.xml 0001972481-26-000157 000-19125 26974660 33 6165
2026-05-06 4 PRIMARY DOCUMENT 0000874015-26-000183 27712
2026-05-05 4 PRIMARY DOCUMENT 0000874015-26-000182 11789
2026-05-04 144 xsl144X01/primary_doc.xml 0001972481-26-000144 000-19125 26939526 33 7734
2026-04-30 4 PRIMARY DOCUMENT 0000874015-26-000179 6123
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000716 005-41771 26921380 34 7414
2026-04-29 10-Q IONIS PHARMACEUTICALS, INC. 10-Q 03-31-2026 0000874015-26-000177 000-19125 26914180 34 6413858 1 1
2026-04-29 8-K 8-K 2.02,9.01 0001140361-26-017637 000-19125 26910464 34 551242 1 1
2026-04-28 144 xsl144X01/primary_doc.xml 0001972481-26-000138 000-19125 26907895 33 6216
2026-04-23 ARS ARS 0001140361-26-016395 000-19125 26889002 34 1878255
2026-04-23 DEFA14A DEFA14A 0001140361-26-016391 000-19125 26888984 34 2256181
2026-04-23 DEF 14A DEF 14A 0001140361-26-016388 000-19125 26888976 34 13651330 1 1
2026-04-21 8-K 8-K 7.01,8.01,9.01 0001140361-26-015801 000-19125 26876704 34 214904 1 1
2026-04-17 4 PRIMARY DOCUMENT 0000874015-26-000172 7287
2026-04-17 4 PRIMARY DOCUMENT 0000874015-26-000171 9651
2026-04-17 4 PRIMARY DOCUMENT 0000874015-26-000170 9656
2026-04-17 4 PRIMARY DOCUMENT 0000874015-26-000169 10358
2026-04-16 144 xsl144X01/primary_doc.xml 0000874015-26-000164 000-19125 26868902 33 5466
2026-04-16 144 xsl144X01/primary_doc.xml 0000874015-26-000163 000-19125 26868892 33 5457
2026-04-16 144 xsl144X01/primary_doc.xml 0000874015-26-000162 000-19125 26868888 33 6084
2026-04-02 4 PRIMARY DOCUMENT 0000874015-26-000161 15180
2026-04-02 4 PRIMARY DOCUMENT 0000874015-26-000160 5432
2026-03-31 144 xsl144X01/primary_doc.xml 0001972481-26-000123 000-19125 26823698 33 4970
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001551 005-41771 26801669 34 7178
2026-03-24 144/A xsl144X01/primary_doc.xml 0001972481-26-000116 000-19125 26787014 33 5701
2026-03-23 4 PRIMARY DOCUMENT 0000874015-26-000152 5480
2026-03-19 144 xsl144X01/primary_doc.xml 0001972481-26-000114 000-19125 26774133 33 5026
2026-03-18 4 PRIMARY DOCUMENT 0000874015-26-000146 23078
2026-03-16 144 xsl144X01/primary_doc.xml 0001972481-26-000103 000-19125 26757293 33 5776
2026-03-11 4 PRIMARY DOCUMENT 0000874015-26-000144 5250
2026-03-11 4 PRIMARY DOCUMENT 0000874015-26-000143 23416
2026-03-11 4 PRIMARY DOCUMENT 0000874015-26-000142 14078
2026-03-10 144 xsl144X01/primary_doc.xml 0001972481-26-000093 000-19125 26739080 33 5530
2026-03-09 144 xsl144X01/primary_doc.xml 0001972481-26-000092 000-19125 26735168 33 5620
2026-03-09 8-K 8-K 5.02,7.01,9.01 0001140361-26-008340 000-19125 26733148 34 182686 1 1
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000138 13441
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000137 17016
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000136 19380
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000135 26235
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000134 16129
2026-03-05 4 PRIMARY DOCUMENT 0000874015-26-000133 26058
2026-03-03 144/A xsl144X01/primary_doc.xml 0001972481-26-000083 000-19125 26717151 33 6432
2026-03-03 144 xsl144X01/primary_doc.xml 0001972481-26-000082 000-19125 26717131 33 4433
2026-03-03 144 xsl144X01/primary_doc.xml 0001972481-26-000081 000-19125 26717088 33 5513
2026-03-03 144 xsl144X01/primary_doc.xml 0001972481-26-000080 000-19125 26717078 33 5631
2026-03-03 144 xsl144X01/primary_doc.xml 0001972481-26-000078 000-19125 26716998 33 4973
2026-03-03 144 xsl144X01/primary_doc.xml 0001972481-26-000077 000-19125 26716986 33 7791
2026-03-03 4 PRIMARY DOCUMENT 0000874015-26-000125 5446
2026-03-03 4 PRIMARY DOCUMENT 0000874015-26-000124 4768
2026-03-03 4 PRIMARY DOCUMENT 0000874015-26-000123 4797
2026-03-03 4 PRIMARY DOCUMENT 0000874015-26-000122 4804
2026-03-03 4 PRIMARY DOCUMENT 0000874015-26-000121 4868
2026-02-26 10-K IONIS PHARMACEUTICALS, INC. 10-K 12-31-2025 0000874015-26-000115 000-19125 26688958 34 13944684 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001140361-26-006718 000-19125 26674178 34 670476 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-26-000248 005-41771 26637766 34 7557
2026-02-13 4/A PRIMARY DOCUMENT 0000874015-26-000112 5070
2026-02-13 4 PRIMARY DOCUMENT 0000874015-26-000111 7905
2026-02-13 4 PRIMARY DOCUMENT 0000874015-26-000110 5174
2026-02-13 144 xsl144X01/primary_doc.xml 0001972481-26-000055 000-19125 26632512 33 6172
2026-02-11 144 xsl144X01/primary_doc.xml 0001972481-26-000053 000-19125 26620631 33 4402
2026-02-10 4 PRIMARY DOCUMENT 0000874015-26-000106 5279
2026-02-06 144 xsl144X01/primary_doc.xml 0001972481-26-000045 000-19125 26607678 33 5611
2026-02-04 4 PRIMARY DOCUMENT 0000874015-26-000104 15335
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000102 7744
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000101 7099
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000100 7065
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000099 7098
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000098 7267
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000097 7101
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000096 7164
2026-02-02 4 PRIMARY DOCUMENT 0000874015-26-000095 7800
2026-02-02 144 xsl144X01/primary_doc.xml 0001972481-26-000034 000-19125 26588170 33 6199
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000086 000-19125 26585359 33 4879
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000085 000-19125 26585354 33 4863
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000084 000-19125 26585344 33 4924
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000083 000-19125 26585332 33 5036
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000082 000-19125 26585329 33 4928
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000081 000-19125 26585326 33 4872
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000080 000-19125 26585323 33 5440
2026-01-30 144 xsl144X01/primary_doc.xml 0000874015-26-000078 000-19125 26585301 33 4860
2026-01-23 4 PRIMARY DOCUMENT 0000874015-26-000077 5296
2026-01-23 144/A xsl144X01/primary_doc.xml 0001972481-26-000032 000-19125 26556346 33 6294
2026-01-22 144 xsl144X01/primary_doc.xml 0001972481-26-000027 000-19125 26551636 33 5622
2026-01-21 144 xsl144X01/primary_doc.xml 0000874015-26-000075 000-19125 26545531 33 4266
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000073 7209
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000072 22274
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000071 14608
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000070 14574
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000069 14612
2026-01-20 4/A PRIMARY DOCUMENT 0000874015-26-000068 5900
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000067 14030
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000066 14563
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000065 14781
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000064 14620
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000063 14610
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000062 14673
2026-01-20 4 PRIMARY DOCUMENT 0000874015-26-000061 22353
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000045 000-19125 26540783 33 4843
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000043 000-19125 26540731 33 4283
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000040 000-19125 26540725 33 4327
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000038 000-19125 26540714 33 4266
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000037 000-19125 26540709 33 4440
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000036 000-19125 26540707 33 4329
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000035 000-19125 26540704 33 4364
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000034 000-19125 26540701 33 4275
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000033 000-19125 26540699 33 4263
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000031 000-19125 26540696 33 4262
2026-01-16 144 xsl144X01/primary_doc.xml 0000874015-26-000030 000-19125 26540692 33 5526
2026-01-12 8-K 8-K 2.02,9.01 0001140361-26-000893 000-19125 26524622 34 209679 1 1
2026-01-09 4 PRIMARY DOCUMENT 0000874015-26-000029 28602
2026-01-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422849-26-000001 005-41771 26517014 34 7378
2026-01-07 144 xsl144X01/primary_doc.xml 0001972481-26-000017 000-19125 26515772 33 6652
2026-01-07 8-K 8-K 7.01,8.01,9.01 0001140361-26-000435 000-19125 26513876 34 191241 1 1
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000027 5717
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000026 19974
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000025 5724
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000024 5690
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000023 5718
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000022 5822
2026-01-06 3 PRIMARY DOCUMENT 0000874015-26-000021 16881
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000020 5891
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000019 5736
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000018 5726
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000017 5787
2026-01-06 4 PRIMARY DOCUMENT 0000874015-26-000016 8430
2026-01-02 144 xsl144X01/primary_doc.xml 0001972481-26-000010 000-19125 26502979 33 5566
2025-12-03 4 PRIMARY DOCUMENT 0000874015-25-000288 7956
2025-12-01 144/A xsl144X01/primary_doc.xml 0001958244-25-004499 000-19125 251541153 33 15511
2025-12-01 144 xsl144X01/primary_doc.xml 0001958244-25-004498 000-19125 251541071 33 13795
2025-11-28 4 PRIMARY DOCUMENT 0000874015-25-000286 20717
2025-11-28 4 PRIMARY DOCUMENT 0000874015-25-000285 8733
2025-11-25 144 xsl144X01/primary_doc.xml 0001972481-25-000287 000-19125 251522897 33 6150
2025-11-25 144 xsl144X01/primary_doc.xml 0001969223-25-000992 000-19125 251520981 33 6484
2025-11-20 4 PRIMARY DOCUMENT 0000874015-25-000282 7348
2025-11-20 4 PRIMARY DOCUMENT 0000874015-25-000281 13262
2025-11-19 144 xsl144X01/primary_doc.xml 0001958244-25-004467 000-19125 251500374 33 5896
2025-11-17 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-25-284609 000-19125 251491121 34 987403 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000512 005-41771 251483374 34 7564
2025-11-10 8-K 8-K 7.01,8.01,9.01 0001140361-25-041225 000-19125 251464148 34 211885 1 1
2025-11-07 4 PRIMARY DOCUMENT 0000874015-25-000278 5285
2025-11-07 4 PRIMARY DOCUMENT 0000874015-25-000277 24269
2025-11-07 4/A PRIMARY DOCUMENT 0000874015-25-000276 13796
2025-11-03 4 PRIMARY DOCUMENT 0000874015-25-000272 11572
2025-11-03 4 PRIMARY DOCUMENT 0000874015-25-000271 8653
2025-11-03 4 PRIMARY DOCUMENT 0000874015-25-000270 25204
2025-11-03 8-K/A 8-K/A 1.01,9.01 0001140361-25-040220 000-19125 251445232 34 2357469 1 1
2025-10-31 144 xsl144X01/primary_doc.xml 0001972481-25-000259 000-19125 251440859 33 5013
2025-10-31 144 xsl144X01/primary_doc.xml 0001972481-25-000258 000-19125 251440850 33 7233
2025-10-30 144 xsl144X01/primary_doc.xml 0001958244-25-004424 000-19125 251437421 33 16954
2025-10-29 10-Q IONIS PHARMACEUTICALS, INC. 10-Q 9-30-2025 0000874015-25-000266 000-19125 251430586 34 6821854 1 1
2025-10-29 8-K 8-K 2.02,9.01 0001140361-25-039650 000-19125 251426794 34 718254 1 1
2025-10-16 4 PRIMARY DOCUMENT 0000874015-25-000262 9815
2025-10-16 4 PRIMARY DOCUMENT 0000874015-25-000261 5175
2025-10-16 4 PRIMARY DOCUMENT 0000874015-25-000260 14468
2025-10-16 4 PRIMARY DOCUMENT 0000874015-25-000259 14095
2025-10-15 144 xsl144X01/primary_doc.xml 0001972481-25-000250 000-19125 251394935 33 6075
2025-10-15 144 xsl144X01/primary_doc.xml 0001972481-25-000249 000-19125 251394917 33 5561
2025-10-14 144 xsl144X01/primary_doc.xml 0001972481-25-000248 000-19125 251392472 33 4958
2025-10-08 4 PRIMARY DOCUMENT 0000874015-25-000254 5925
2025-10-08 4 PRIMARY DOCUMENT 0000874015-25-000253 10666
2025-10-08 4 PRIMARY DOCUMENT 0000874015-25-000252 4707
2025-10-08 4 PRIMARY DOCUMENT 0000874015-25-000251 5980
2025-10-06 144 xsl144X01/primary_doc.xml 0001972481-25-000240 000-19125 251377919 33 6775
2025-10-06 144 xsl144X01/primary_doc.xml 0001972481-25-000239 000-19125 251377879 33 6808
2025-10-06 144 xsl144X01/primary_doc.xml 0001972481-25-000238 000-19125 251377861 33 6176
2025-10-02 4 PRIMARY DOCUMENT 0000874015-25-000246 5293
2025-10-02 4 PRIMARY DOCUMENT 0000874015-25-000245 14734
2025-10-02 4 PRIMARY DOCUMENT 0000874015-25-000244 13520
2025-10-02 4 PRIMARY DOCUMENT 0000874015-25-000243 9417
2025-10-02 144 xsl144X01/primary_doc.xml 0001972481-25-000231 000-19125 251371119 33 9564
2025-10-02 144 xsl144X01/primary_doc.xml 0001972481-25-000230 000-19125 251370906 33 6209
2025-10-01 144 xsl144X01/primary_doc.xml 0001958244-25-004364 000-19125 251365742 33 13313
2025-10-01 4 PRIMARY DOCUMENT 0000874015-25-000240 14057
2025-10-01 4 PRIMARY DOCUMENT 0000874015-25-000239 8710
2025-10-01 4 PRIMARY DOCUMENT 0000874015-25-000238 8889
2025-10-01 144 xsl144X01/primary_doc.xml 0001972481-25-000223 000-19125 251365162 33 4978
2025-09-30 144 xsl144X01/primary_doc.xml 0001972481-25-000222 000-19125 251361188 33 5598
2025-09-30 144 xsl144X01/primary_doc.xml 0001972481-25-000221 000-19125 251361049 33 4599
2025-09-22 8-K 8-K 7.01,8.01,9.01 0001140361-25-035634 000-19125 251328383 34 190955 1 1
2025-09-16 4 PRIMARY DOCUMENT 0000874015-25-000234 8682
2025-09-11 4 PRIMARY DOCUMENT 0000874015-25-000232 9418
2025-09-11 4 PRIMARY DOCUMENT 0000874015-25-000231 13524
2025-09-09 4 PRIMARY DOCUMENT 0000874015-25-000228 8837
2025-09-09 4 PRIMARY DOCUMENT 0000874015-25-000227 5343
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000224 7903
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000223 9490
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000222 7151
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000221 22854
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000220 13637
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000219 13637
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000218 5275
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000217 12121
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000216 9490
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000215 18174
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000214 22938
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000213 12160
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000212 8655
2025-09-04 4 PRIMARY DOCUMENT 0000874015-25-000211 10698
2025-09-03 4 PRIMARY DOCUMENT 0000874015-25-000193 4760
2025-09-03 4 PRIMARY DOCUMENT 0000874015-25-000191 4789
2025-09-03 4 PRIMARY DOCUMENT 0000874015-25-000190 4788
2025-09-03 4 PRIMARY DOCUMENT 0000874015-25-000189 4861
2025-09-03 4 PRIMARY DOCUMENT 0000874015-25-000187 4799
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000194 000-19125 251291220 33 4432
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000193 000-19125 251290965 33 5031
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000192 000-19125 251290627 33 7334
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000191 000-19125 251290359 33 4443
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000190 000-19125 251290182 33 6670
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000189 000-19125 251290058 33 4951
2025-09-03 144 xsl144X01/primary_doc.xml 0001972481-25-000188 000-19125 251290039 33 5611
2025-09-03 144 xsl144X01/primary_doc.xml 0001969223-25-000715 000-19125 251289574 33 4689
2025-09-02 144 xsl144X01/primary_doc.xml 0001958244-25-004293 000-19125 251287484 33 13684
2025-09-02 144 xsl144X01/primary_doc.xml 0001972481-25-000187 000-19125 251286756 33 4305
2025-09-02 144 xsl144X01/primary_doc.xml 0001972481-25-000185 000-19125 251286178 33 5016
2025-09-02 144 xsl144X01/primary_doc.xml 0001972481-25-000184 000-19125 251286039 33 4435
2025-09-02 144 xsl144X01/primary_doc.xml 0001972481-25-000183 000-19125 251285620 33 4986
2025-09-02 8-K 8-K 7.01,8.01,9.01 0001140361-25-033541 000-19125 251282925 34 214032 1 1
2025-08-29 144 xsl144X01/primary_doc.xml 0000048532-25-000002 000-19125 251279008 33 4507
2025-08-26 4 PRIMARY DOCUMENT 0000874015-25-000180 5213
2025-08-21 8-K 8-K 7.01,8.01,9.01 0001140361-25-032176 000-19125 251240061 34 193607 1 1
2025-08-20 4 PRIMARY DOCUMENT 0000874015-25-000178 8782
2025-08-18 144 xsl144X01/primary_doc.xml 0001972481-25-000175 000-19125 251228238 33 5547
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000331 005-41771 251204913 34 15338
2025-08-08 4 PRIMARY DOCUMENT 0000874015-25-000176 7149
2025-08-06 4 PRIMARY DOCUMENT 0000874015-25-000174 5274
2025-08-06 144 xsl144X01/primary_doc.xml 0001972481-25-000167 000-19125 251189648 33 4278
2025-08-05 4 PRIMARY DOCUMENT 0000874015-25-000172 5282
2025-08-05 144 xsl144X01/primary_doc.xml 0001972481-25-000165 000-19125 251185238 33 4416
2025-08-04 144 xsl144X01/primary_doc.xml 0001972481-25-000157 000-19125 251180132 33 9753
2025-08-01 4 PRIMARY DOCUMENT 0000874015-25-000170 8140
2025-07-30 144 xsl144X01/primary_doc.xml 0001972481-25-000150 000-19125 251167902 33 5013
2025-07-30 S-8 S-8 0001140361-25-028020 333-289093 251167454 33 213990 1 1
2025-07-30 10-Q IONIS PHARMACEUTICALS, INC. 10-Q 6-30-2025 0000874015-25-000167 000-19125 251166815 34 9531144 1 1
2025-07-30 8-K 8-K 2.02,9.01 0001140361-25-027949 000-19125 251165048 34 641961 1 1
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000162 7379
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000161 7378
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000160 7453
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000159 7338
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000158 7374
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000157 8360
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000156 7376
2025-07-17 4 PRIMARY DOCUMENT 0000874015-25-000155 8436
2025-07-15 4 PRIMARY DOCUMENT 0000874015-25-000146 5278
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000144 8886
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000143 8841
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000142 8844
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000141 8885
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000140 8889
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000139 8880
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000138 8906
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000137 8882
2025-07-02 4 PRIMARY DOCUMENT 0000874015-25-000136 8913
2025-06-12 8-K 8-K 5.02,9.01 0001140361-25-022267 000-19125 251041775 34 168753 1 1
2025-06-10 8-K 8-K 5.07,9.01 0001140361-25-022001 000-19125 251035872 34 169778 1 1
2025-05-19 8-K 8-K 8.01,9.01 0001140361-25-019620 000-19125 25961490 34 183591 1 1
2025-05-02 4 PRIMARY DOCUMENT 0000874015-25-000125 6023
2025-04-30 10-Q IONIS PHARMACEUTICALS, INC. 10-Q 3-31-2025 0000874015-25-000123 000-19125 25894677 34 8274083 1 1
2025-04-30 8-K 8-K 2.02,9.01 0001140361-25-016562 000-19125 25892200 34 524159 1 1
2025-04-25 ARS ARS 0001140361-25-015774 000-19125 25874538 34 12724082
2025-04-25 DEFA14A DEFA14A 0001140361-25-015772 000-19125 25874515 34 7437080
2025-04-25 DEF 14A DEF 14A 0001140361-25-015771 000-19125 25874502 34 13814254 1 1
2025-04-17 4 PRIMARY DOCUMENT 0000874015-25-000120 8948
2025-04-17 4 PRIMARY DOCUMENT 0000874015-25-000119 9436
2025-04-17 4 PRIMARY DOCUMENT 0000874015-25-000118 10220
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000762 005-41771 25844719 34 11110
2025-04-16 144 xsl144X01/primary_doc.xml 0000874015-25-000109 000-19125 25843728 33 4261
2025-04-16 144 xsl144X01/primary_doc.xml 0000874015-25-000108 000-19125 25843725 33 4860
2025-04-16 144 xsl144X01/primary_doc.xml 0000874015-25-000107 000-19125 25843720 33 4880
2025-03-13 4 PRIMARY DOCUMENT 0000874015-25-000105 4711
2025-03-12 8-K 8-K 1.01,9.01 0001140361-25-008178 000-19125 25729693 34 184724 1 1
2025-03-11 144 xsl144X01/primary_doc.xml 0001972481-25-000050 000-19125 25727536 33 6257
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000103 5452
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000102 4774
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000101 4803
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000100 4802
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000099 4810
2025-03-04 4 PRIMARY DOCUMENT 0000874015-25-000098 4871
2025-02-24 4 PRIMARY DOCUMENT 0000874015-25-000091 4685
2025-02-19 10-K IONIS PHARMACEUTICALS, INC. 10-K 12-31-2024 0000874015-25-000089 000-19125 25639940 34 17917973 1 1
2025-02-19 8-K 8-K 2.02,9.01 0001140361-25-005080 000-19125 25637915 34 624587 1 1
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001422849-25-000016 005-41771 25621208 34 7295
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000055 005-41771 25600296 34 7560
2025-02-06 4 PRIMARY DOCUMENT 0000874015-25-000085 5258
2025-02-06 4 PRIMARY DOCUMENT 0000874015-25-000084 5287
2025-02-04 144/A xsl144X01/primary_doc.xml 0001972481-25-000021 000-19125 25589536 33 8038
2025-02-04 144 xsl144X01/primary_doc.xml 0001972481-25-000020 000-19125 25589261 33 7902
2025-02-04 144 xsl144X01/primary_doc.xml 0001972481-25-000019 000-19125 25589066 33 7281
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000081 7752
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000080 7108
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000079 7074
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000078 7106
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000077 7277
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000076 7103
2025-02-03 4 PRIMARY DOCUMENT 0000874015-25-000075 7171
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000074 000-19125 25579664 33 4858
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000073 000-19125 25579661 33 4860
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000072 000-19125 25579274 33 5453
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000071 000-19125 25579260 33 4878
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000070 000-19125 25579251 33 5041
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000068 000-19125 25579197 33 4930
2025-01-31 144 xsl144X01/primary_doc.xml 0000874015-25-000067 000-19125 25579190 33 5541
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000066 7230
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000065 22281
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000064 14617
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000063 14584
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000062 14622
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000061 8659
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000060 14788
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000059 14614
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000058 14630
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000057 14048
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000056 14681
2025-01-17 4 PRIMARY DOCUMENT 0000874015-25-000055 21788
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000042 000-19125 25536749 33 4857
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000041 000-19125 25536746 33 4270
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000040 000-19125 25536744 33 4282
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000039 000-19125 25536743 33 4943
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000038 000-19125 25536742 33 4445
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000037 000-19125 25536737 33 4264
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000036 000-19125 25536734 33 4279
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000035 000-19125 25536730 33 4273
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000034 000-19125 25536724 33 4334
2025-01-16 144 xsl144X01/primary_doc.xml 0000874015-25-000033 000-19125 25536721 33 4290
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000029 005-41771 25517189 34 6309
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000032 5725
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000031 8374
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000030 5731
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000029 5697
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000028 5725
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000027 5703
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000026 5898
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000018 5743
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000017 5733
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000016 5794
2025-01-06 4 PRIMARY DOCUMENT 0000874015-25-000015 8436

Latest XBRL company facts

One latest value per concept from companyfacts (454 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 166.55M 2026-11-03 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
dei EntityPublicFloat Entity Public Float USD 5.28B 2025-06-30 2025 FY 10-K 2026-02-26 0000874015-26-000115
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt PercentileRank 90 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.59M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 42.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd PeoTotalCompAmt PeoTotalCompAmt USD 13.35M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 139.92 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001140361-26-016388
ffd NetFeeAmt NetFeeAmt USD 75,518.26 2026-07-31 S-8 2026-07-31 0001140361-26-030454
ffd TtlFeeAmt TtlFeeAmt USD 75,518.26 2026-07-31 S-8 2026-07-31 0001140361-26-030454
ffd TtlOfferingAmt TtlOfferingAmt USD 546.84M 2026-07-31 S-8 2026-07-31 0001140361-26-030454
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-31 S-8 2026-07-31 0001140361-26-030454
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 27.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 12.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 109,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 116.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 109.08M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -39.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 3.38B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 10.95M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-19 0000874015-25-000089
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 81.88M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD 12.04M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-03 0001104659-14-015019
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -136.62M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD -19.24M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 132.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 1.86M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 89.75M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 132.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 36.16M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 6.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 4.90M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 231,000 2013-12-31 2013 FY 10-K 2014-03-03 0001104659-14-015019
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.20M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap Assets Assets USD 2.91B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AssetsCurrent Assets, Current USD 2.36B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 125,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 10.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.64B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 1.87B 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 556,000 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 4.07M 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 1.87B 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2020-09-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 170,000 2020-09-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 225.96M 2020-09-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 596,000 2021-03-31 2021 Q1 10-Q 2021-05-05 0000874015-21-000074
us-gaap AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1 Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2012-01-31) USD -359,000 2012-06-30 2012 Q2 10-Q 2012-08-06 0001104659-12-054509
us-gaap AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2 Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2013-01-31) USD 744,000 2013-06-30 2013 Q2 10-Q 2013-08-06 0001104659-13-060361
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 435.24M 2021-03-31 2021 Q1 10-Q 2021-05-05 0000874015-21-000074
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 7.00M 2020-09-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 340.62M 2011-03-31 2011 Q1 10-Q 2011-05-06 0001104659-11-026440
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.63B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 1.07B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 560.93M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 31.60M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001104659-13-038211
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 248,000 2013-03-31 2013 Q1 10-Q 2013-05-07 0001104659-13-038211
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions (Deprecated 2013-01-31) security 98 2013-06-30 2013 Q2 10-Q 2013-08-06 0001104659-13-060361
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions Investment 414 2021-03-31 2021 Q1 10-Q 2021-05-05 0000874015-21-000074
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 478,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 770,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-28 0001104659-13-016208
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 296.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 149.19M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 296.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -153.11M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0000874015-20-000115
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -75.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 8.93 2006-04-30 2013 FY 10-K 2014-03-03 0001104659-14-015019
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 8.93 2006-04-30 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 4.25M 2006-04-30 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2011-04-30 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 2.80M 2020-06-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 166.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 166.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CommonStockValue Common Stock, Value, Issued USD 166,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -331.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -294.53M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap ContractualObligation Contractual Obligation USD 1.26B 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 57.44M 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 3.49M 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 1.18B 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 3.50M 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 4.18M 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 4.18M 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 88.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 233.36M 2017-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 70.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 48.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 78.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 596.36M 2019-09-30 2019 Q3 10-Q 2019-11-06 0000874015-19-000130
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 141.45M 2011-12-31 2012 FY 10-K 2013-02-28 0001104659-13-016208
us-gaap CostMethodInvestments Cost Method Investments USD 625,000 2013-12-31 2013 FY 10-K 2014-03-03 0001104659-14-015019
us-gaap CostMethodInvestmentsFairValueDisclosure Cost Method Investments, Fair Value Disclosure USD 625,000 2013-12-31 2013 FY 10-K 2014-03-03 0001104659-14-015019
us-gaap CostmethodInvestmentsOtherThanTemporaryImpairment Cost-method Investments, Other than Temporary Impairment USD 4.40M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap CostMethodInvestmentsRealizedLosses Cost-method Investments, Realized Losses USD 267,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-08 0001104659-11-061713
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 9.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CostsAndExpenses Costs and Expenses USD 1.11B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap CumulativeEffectOfInitialAdoptionOfNewAccountingPrinciple Cumulative Effect of Initial Adoption of New Accounting Principle (Deprecated 2011-01-31) USD -11.58M 2010-01-01 2010-12-31 2010 FY 10-K 2011-03-01 0001104659-11-011094
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -1.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 221,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 839.57M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 178.78M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap DebtInstrumentConvertibleEffectiveInterestRate Debt Instrument, Convertible, Effective Interest Rate (Deprecated 2013-01-31) USD 0.026 2010-01-01 2010-12-31 2010 FY 10-K 2011-03-01 0001104659-11-011094
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 500.00M 2014-10-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.01 2014-10-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 101.82M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 1.07B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 568.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 8.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 84,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 1.48B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 10.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Investment 563 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 1.49B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 10.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Decrease in Unrecognized Tax Benefits is Reasonably Possible USD 7.60M 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 26.25M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredRentCredit Deferred Rent Credit USD 17.31M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 106.47M 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 72.71M 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 38.83M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 76.28M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 1.31B 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.09M 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 285.00M 2019-09-30 2019 Q3 10-Q 2019-11-06 0000874015-19-000130
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 290.85M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 12.76M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 361.06M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 210.46M 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 67.58M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges USD 2.37M 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 1.24B 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxLiabilitiesFinancingArrangements Deferred Tax Liabilities, Financing Arrangements USD 2.92M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 58.74M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 7.15M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DeferredTaxLiabilitiesOtherComprehensiveIncome Deferred Tax Liabilities, Other Comprehensive Income USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 8.06M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 10.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap Depreciation Depreciation USD 10.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 5.33M 2008-01-01 2008-12-31 2010 FY 10-K 2011-03-01 0001104659-11-011094
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 10.74M 2018-10-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 185.66M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax USD -29,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD 16.80M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.15 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.247 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.024 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 459,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure -0.044 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap EffectiveIncomeTaxRateReconciliationFdiiAmount EffectiveIncomeTaxRateReconciliationFdiiAmount USD 21.07M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure -0.046 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.051 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.051 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.032 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.116 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.047 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -154,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000874015-22-000104
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 702,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -199,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 61.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 556,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 7.60M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) Y 1.3 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestments Equity Method Investments USD -4.42M 2011-12-31 2012 FY 10-K 2013-02-28 0001104659-13-016208
us-gaap EquityMethodInvestmentSummarizedFinancialInformationAssets Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) USD 42.88M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCostOfSales Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) USD 20.93M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets Equity Method Investment, Summarized Financial Information, Current Assets (Deprecated 2020-01-31) USD 38.67M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities Equity Method Investment, Summarized Financial Information, Current Liabilities (Deprecated 2020-01-31) USD 12.85M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) USD -7.14M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationLiabilities Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) USD 41.68M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) USD -7.60M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets Equity Method Investment, Summarized Financial Information, Noncurrent Assets (Deprecated 2020-01-31) USD 4.21M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities (Deprecated 2020-01-31) USD 28.83M 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquityMethodInvestmentSummarizedFinancialInformationRevenue Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) USD 13.79M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 77.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EquitySecuritiesFvNiCost Equity Securities, FV-NI, Cost USD 21.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0000874015-19-000130
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 606,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0000874015-19-000130
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 278,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD -1.44M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 5.04M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 3.60M 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 29.61M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000874015-22-000168
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 3.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -12,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000874015-25-000089
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 21.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 20.30M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income USD 19.90M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 72,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-28 0001104659-13-016208
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 48.62M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 1.30M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -381.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -315.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -89.74M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-05 0000874015-21-000074
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -84.80M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.85 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.85 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 185.63M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 1.89 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 1.89 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2.07M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000874015-24-000232
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation USD 2,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-07 0000874015-14-000095
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD -37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD -648,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 93.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 10.81M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Amount USD 2.41M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -118,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -79.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD 2.79M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 4.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 19.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -288,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 4,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 353,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 12.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 53.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 17.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4.59M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 22.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -46.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 125,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 36.70M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable USD 2.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 46.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 46.70M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 15.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInOtherEmployeeRelatedLiabilities Increase (Decrease) in Other Employee-Related Liabilities USD -54.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 60.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 10.26M 2018-10-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 16.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap InterestExpense Interest Expense USD 14.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 106,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 26.04M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 2.12M 2025-03-31 2025 Q1 10-Q 2025-04-30 0000874015-25-000123
us-gaap InventoryNet Inventory, Net USD 28.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 640,000 2025-03-31 2025 Q1 10-Q 2025-04-30 0000874015-25-000123
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 9.07M 2018-06-30 2018 Q2 10-Q 2018-08-07 0000874015-18-000105
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 8.74M 2025-03-31 2025 Q1 10-Q 2025-04-30 0000874015-25-000123
us-gaap InventoryWriteDown Inventory Write-down USD 0 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap InvestmentIncomeNet Investment Income, Net USD 65.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD -1.75M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-05 0000874015-15-000057
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 714.82M 2015-06-30 2015 Q2 10-Q 2015-08-05 0000874015-15-000077
us-gaap Land Land USD 10.20M 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.80M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001140361-15-009498
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 484.82M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 306.00M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 35.53M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 34.89M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 34.95M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 36.88M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 36.56M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 212.92M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap Liabilities Liabilities USD 2.52B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.91B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap LiabilitiesCurrent Liabilities, Current USD 435.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap LoansPayableToBank Loans Payable to Bank USD 8.56M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebt Long-term Debt USD 1.81B 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 539.11M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 300.46M 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 432.12M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 300,000 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 443.16M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 770.06M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 60,000 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 580.09M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 18.74M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.33B 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 28.12M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2020-12-31 2020 FY 10-K 2021-02-24 0000874015-21-000056
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 544.69M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap MinorityInterestIncreaseFromStockIssuance Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) USD 10.00M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap MinorityInterestPeriodIncreaseDecrease Noncontrolling Interest, Period Increase (Decrease) USD -35.48M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 29.54M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 0 2010-01-01 2010-12-31 2010 FY 10-K 2011-03-01 0001104659-11-011094
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -329.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 75.55M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 660.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -168.68M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -406.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 122.67M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0000874015-17-000033
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -317.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 123.55M 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-07-29 0000874015-26-000251
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 127.56M 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-07-29 0000874015-26-000251
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 30,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap NotesIssued1 Notes Issued USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap NotesReduction Notes Reduction USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OperatingExpenses Operating Expenses USD 661.05M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -350.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 26.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 271.89M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 9.51M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 262.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OperatingLeasePayments Operating Lease, Payments USD 24.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 228.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 10.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 24.48M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.88M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.53M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.47M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.60M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.88M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 16.13M 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 17.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherAssetsCurrent Other Assets, Current USD 360.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 161.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 1.63M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-04-30 0000874015-25-000123
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -199,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD 15.67M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001104659-13-060361
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax USD 5.10M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-05 0000874015-15-000057
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax Other Comprehensive Income (Loss), before Reclassifications, before Tax USD 7.37M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-05 0000874015-15-000057
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -24.81M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -14,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0000874015-17-000054
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD -1.16M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001104659-13-060361
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) USD -138,000 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -14.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 12.80M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap OtherLiabilities Other Liabilities USD 32.79M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 22.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 20.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 168,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0000874015-18-000060
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 805,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 880,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-08 0001104659-11-061713
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities USD 880,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-07 0001104659-13-038211
us-gaap PaymentsForHedgeFinancingActivities Payments for Hedge, Financing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -25.53M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000874015-25-000089
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0000874015-21-000166
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 11.20M 2024-09-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000874015-24-000232
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000874015-25-000089
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 706.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000874015-22-000168
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 5.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap PaymentsToAcquireLand Payments to Acquire Land USD 10.10M 2010-03-01 2010-03-31 2015 FY 10-K 2016-02-26 0000874015-16-000112
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 3.18M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-04 0000874015-21-000144
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 50.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 110.16M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-06 0001104659-11-026440
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.06 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-06 0000874015-18-000128
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0000874015-25-000089
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries Proceeds from Divestiture of Interest in Consolidated Subsidiaries USD 175.00M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 103.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-21 0000874015-24-000116
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 10.00M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD 12.60M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 1.42B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 4.47M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap ProceedsFromSaleOfLandHeldForUse Proceeds from Sale of Land Held-for-use USD 10.15M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-28 0001104659-13-016208
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 19.60M 2025-09-01 2025-09-30 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 170.33M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-06 0001104659-11-026440
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -269.72M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 162.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 21.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs USD 62.95M 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 432.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-04 0000874015-20-000142
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 12.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001140361-20-004500
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000874015-22-000079
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 128,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RepaymentsOfSubordinatedDebt Repayments of Subordinated Debt USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001140361-17-009823
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 915.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.95B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 756.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 60.50M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001104659-13-081234
us-gaap Revenues Revenues USD 203.33M 2025-10-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 112.54M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap SaleAndLeasebackTransactionGainLossNet Sale and Leaseback Transaction, Gain (Loss), Net USD 4.20M 2025-09-01 2025-09-30 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.68 2017-07-19 2017-12-31 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap SaleOfStockPercentageOfOwnershipBeforeTransaction Sale of Stock, Percentage of Ownership before Transaction pure 1 2017-01-01 2017-07-18 2017 FY 10-K 2018-02-28 0000874015-18-000047
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 454.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 132.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 132.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap SharePrice Share Price USD/shares 19 2013-06-30 2013 Q3 10-Q 2013-11-05 0001104659-13-081234
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 43.5 2024-09-30 2024 Q3 10-Q 2024-11-06 0000874015-24-000232
us-gaap ShortTermInvestments Short-term Investments USD 1.59B 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap SquareFootageOfRealEstateProperty Square Footage of Real Estate Property (Deprecated 2012-01-31) sqft 176,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001104659-12-014567
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 393.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 315.46M 2023-09-30 2023 Q3 10-Q 2023-11-02 0000874015-23-000209
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 11.50M 2024-09-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000874015-24-000232
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 489.12M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 103.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 90.55M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 1.50M 2020-01-01 2020-03-31 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 125.00M 2019-09-30 2022 FY 10-K 2023-02-22 0000874015-23-000105
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 53.96M 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0000874015-19-000045
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 7.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 5.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 137,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 200,000 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 107.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0000874015-26-000115
us-gaap ValuationAllowancesAndReservesReservesOfBusinessesAcquired SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired USD 359,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-08 0001104659-11-061713
us-gaap VariableInterestEntityNonconsolidatedCarryingAmountAssets Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets (Deprecated 2020-01-31) USD 18.60M 2015-09-30 2015 Q3 10-Q 2015-11-09 0000874015-15-000082
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 165.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 123.43M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0000874015-17-000054
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 165.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0000874015-26-000271

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →